Literature DB >> 19318431

No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.

Alicia Beeghly-Fadiel1, Qiuyin Cai, Wei Lu, Jirong Long, Yu-Tang Gao, Xiao-Ou Shu, Wei Zheng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19318431      PMCID： PMC2701308          DOI： 10.1158/1055-9965.EPI-09-0046

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  30 in total

1.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.

Authors:  Giorgio Ghilardi; Maria Luisa Biondi; Maria Caputo; Simona Leviti; Marco DeMonti; Emma Guagnellini; Roberto Scorza
Journal:  Clin Cancer Res       Date:  2002-12       Impact factor: 12.531

3.  Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression.

Authors:  S Ye; P Eriksson; A Hamsten; M Kurkinen; S E Humphries; A M Henney
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

4.  Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts.

Authors:  J A DiBattista; J P Pelletier; M Zafarullah; N Fujimoto; K Obata; J Martel-Pelletier
Journal:  J Rheumatol Suppl       Date:  1995-02

5.  ETS sites in the promoters of the matrix metalloproteinases collagenase (MMP-1) and stromelysin (MMP-3) are auxiliary elements that regulate basal and phorbol-induced transcription.

Authors:  L A White; C Maute; C E Brinckerhoff
Journal:  Connect Tissue Res       Date:  1997       Impact factor: 3.417

6.  A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription.

Authors:  J L Rutter; T I Mitchell; G Butticè; J Meyers; J F Gusella; L J Ozelius; C E Brinckerhoff
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

7.  Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.

Authors:  S Ye; G F Watts; S Mandalia; S E Humphries; A M Henney
Journal:  Br Heart J       Date:  1995-03

8.  The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.

Authors:  Peter Krippl; Uwe Langsenlehner; Wilfried Renner; Babak Yazdani-Biuki; Herwig Köppel; Andreas Leithner; Thomas C Wascher; Bernhard Paulweber; Hellmut Samonigg
Journal:  Clin Cancer Res       Date:  2004-05-15       Impact factor: 12.531

9.  Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells.

Authors:  A Lochter; S Galosy; J Muschler; N Freedman; Z Werb; M J Bissell
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

10.  Transcriptional repression of the human collagenase-1 (MMP-1) gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter.

Authors:  U Benbow; J L Rutter; C H Lowrey; C E Brinckerhoff
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640
View more
  5 in total

1.  No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk.

Authors:  Alicia Beeghly-Fadiel; Yong-Bing Xiang; Sandra L Deming; Ji-Rong Long; Wang-Hong Xu; Qiuyin Cai; Wei Zheng; Xiao Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05-12       Impact factor: 4.254

2.  The association between individual SNPs or haplotypes of matrix metalloproteinase 1 and gastric cancer susceptibility, progression and prognosis.

Authors:  Yong-Xi Song; Xin Zhou; Zhen-Ning Wang; Peng Gao; Ai-Lin Li; Ji-Wang Liang; Jin-Liang Zhu; Ying-Ying Xu; Hui-Mian Xu
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

3.  Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.

Authors:  Ji Wang; Chenyang Ye; Demin Lu; Yongxia Chen; Yunlu Jia; Xiaogang Ying; Hanchu Xiong; Wenhe Zhao; Jichun Zhou; Linbo Wang
Journal:  Oncotarget       Date:  2017-08-24

4.  Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study.

Authors:  Martha L Slattery; Esther John; Gabriela Torres-Mejia; Mariana Stern; Abbie Lundgreen; Lisa Hines; Anna Giuliano; Kathy Baumgartner; Jennifer Herrick; Roger K Wolff
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

Review 5.  Matrix Metallopeptidase 3 Polymorphisms: Emerging genetic Markers in Human Breast Cancer Metastasis.

Authors:  Shafinah Ahmad Suhaimi; Soon Choy Chan; Rozita Rosli
Journal:  J Breast Cancer       Date:  2020-02-18       Impact factor: 3.588
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.